Overall, the results showed that the use of Wnt3a as serum lung tumor marker had good specificity but poor sensitivity (Supplementary Table S5), in contrast, the sensitivity and the specificity of h-Prune detection alone is sufficient to identify lung cancer affected patients. This evidence concerns the gene PRUNE1 and lung carcinoma.